BetterLife Pharma Inc.

CNSX:BETR Stock Report

Market Cap: CA$15.6m

BetterLife Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

CNSX:BETR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Feb 25BuyCA$11,000Stephen SanghaIndividual100,000CA$0.11
20 Jan 25BuyCA$15,480Stephen SanghaIndividual129,000CA$0.12
14 Jan 25BuyCA$23,000Stephen SanghaIndividual200,000CA$0.11
13 Jan 25BuyCA$12,737Stephen SanghaIndividual110,756CA$0.11
10 Jan 25BuyCA$2,777Stephen SanghaIndividual24,152CA$0.11
18 Dec 24BuyCA$1,365Stephen SanghaIndividual13,000CA$0.10
18 Dec 24BuyCA$3,885Stephen SanghaIndividual37,000CA$0.10
17 Dec 24BuyCA$5,533Stephen SanghaIndividual52,700CA$0.10
17 Dec 24BuyCA$5,250Stephen SanghaIndividual50,000CA$0.10
13 Dec 24BuyCA$2,090Stephen SanghaIndividual19,000CA$0.11
12 Dec 24BuyCA$2,875Stephen SanghaIndividual25,000CA$0.12
06 Dec 24BuyCA$9,669Stephen SanghaIndividual87,900CA$0.11
08 Aug 24BuyCA$13,910Stephen SanghaIndividual107,000CA$0.13
14 Jun 24BuyCA$50,000Ahmad DoroudianIndividual500,000CA$0.10
28 Feb 24BuyCA$21,250Stephen SanghaIndividual250,000CA$0.085
13 Feb 24BuyCA$5,895Stephen SanghaIndividual65,500CA$0.09

Insider Trading Volume

Insider Buying: BETR insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BETR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders36,883,82328.5%
General Public92,689,56571.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 8 shareholders own 28.47% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.9%
Stephen Sangha
20,539,756CA$2.5m9.89%no data
10.2%
Ahmad Doroudian
13,263,313CA$1.6m0%no data
1.07%
Hooshmand Sheshbaradaran
1,386,281CA$166.4k0%no data
0.76%
Hamid Doroudian
987,148CA$118.5k0%no data
0.49%
Moira Ong
637,825CA$76.6k0%no data
0.028%
Wolfgang Renz
36,500CA$4.4k0%no data
0.023%
Robert Metcalfe
30,000CA$3.6k0%no data
0.0023%
Ralph Pullen
3,000CA$360.80%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/11 01:51
End of Day Share Price 2025/02/11 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BetterLife Pharma Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.